Stock Taper
Waldencast Acquisition Corp. offers advanced dermatologist-driven skincare products, including Obagi and Obagi Clinical, to reduce signs of aging, hyperpigmentation, and skin damage through professional channels.

Waldencast's Obagi Medical expands into medical aesthetics with an FDA-approved hyaluronic acid filler, signaling a strategic shift toward high-growth categories beyond traditional skincare.
| Icon | PRODUCT | Q4-2022 |
|---|---|---|
![]() | Product | $90.39M |
![]() | Royalty | $1.99M |
| Map | REGION | Q4-2022 |
|---|---|---|
![]() | UNITED STATES | $54.3M |
![]() | CHINA | $17M |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
DUOT | $9.34 | COMPARE |
IMMR | $7.65 | COMPARE |
SVCO | $6.86 | COMPARE |
PERF | $1.89 | COMPARE |
TCX | $10.12 | COMPARE |
AEYE | $7.16 | COMPARE |
ARBE | $0.66 | COMPARE |